Product Information
- (2S,4aS,6aS,7R,10R,11aR,11bS)-2-(3-Furanyl)octahydro-11b-methyl-7,10-methano-2H-pyrano[4,3-g][3]benzoxepin-4,6,8(1H)-trione
- 7,10-Methano-2H-pyrano[4,3-g][3]benzoxepin-4,6,8(1H)-trione, 2-(3-furanyl)octahydro-11b-methyl-, (2S,4aS,6aS,7R,10R,11aR,11bS)-
- 7,10-Methano-2H-pyrano[4,3-g][3]benzoxepin-4,6,8(1H)-trione, 2-(3-furanyl)octahydro-11b-methyl-, [2S-(2α,4aβ,6aα,7α,10α,11aβ,11bα)]-
- NSC 310637
- Neodiosbulbin
Diosbulbin D is a tetrahydrocannabinol (THC) derivative that has been identified as a matrix effect agent. It is a potent, selective and orally active inhibitor of the enzyme fatty acid amide hydrolase (FAAH). Diosbulbin D selectively blocks the hydrolysis of anandamide and other endocannabinoids, which are lipid-signaling molecules produced by the body. This prevents their degradation, leading to increased levels of these compounds in the body. The effects of this drug have been analyzed using LC-MS/MS method on bladder cancer cells, pancreatic cancer cells and skin cancer cells. The results suggest that it may be an effective treatment for cancers characterized by elevated FAAH levels.
Chemical properties
Technical inquiry about: 3D-RCA75657 Diosbulbin D
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
